Baxter International (BAX) Stock: Buy, Sell, or Hold?
BAX - Baxter International Inc.
$23.64
-0.36 (-1.50%)
▼
5d:
+0.68%
30d:
-7.22%
90d:
+4.37%
HOLD
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Oct 29, 2026
26d
Get Alerted When BAX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BAX trades at premium valuation expecting 5.3% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: BAX trades at premium valuation expecting 5.3% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.35
Based on -23.9% avg growth
INTRINSIC VALUE TODAY
$2.70
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BAX is currently trading at $23.64, which is considered slightly low relative to its 30-day fair value range of $23.28 to $25.69. From a valuation perspective, the stock is trading at a premium (Forward PE: 11.6) compared to its historical average (10.0). At these levels, the market is pricing in 5.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, BAX is in a strong downtrend. The price is approaching resistance at $24.30. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BAX scores 81/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $28.73 (+21.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BAX is in a strong downtrend. The price is approaching resistance at $24.30. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BAX scores 81/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $28.73 (+21.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$23.28 -
$25.69
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
89.5%
Protect Your Profits
Holding BAX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (81/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 21.5% below Wall St target ($28.73)
- NEUTRAL: Trading at premium valuation - market expects 5.3% growth which is achievable
- CAUTION: Bottoming setup, but lagging the sector by 20% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$23.28 -
$25.69
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$22.56
Resistance Level
$24.30
Current Trend
Strong Downtrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.61
Wall Street Target
$28.73
(+21.5%)
Revenue Growth (YoY)
5.3%
Earnings Growth (YoY)
36.8%
Profit Margin
-9.3%
Valuation Premium vs History
+5.3% premium
PE vs Historical
11.6 vs 10.0
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.3%
(market-implied from PE analysis)
1-Year Target
$24.89
(+5%)
2-Year Target
$26.21
(+11%)
3-Year Target
$27.60
(+17%)
3-Yr Target (if PE normalizes)
(PE: 12→10)
PE COMPRESSION
$23.78
(+1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: -51.8%)
$40.90
(+73%)
Base:
(SPY PE: 11.6, Growth: -51.8%)
$23.27
(-2%)
Bear:
(PE: 9.9, Growth: -51.8%)
$19.78
(-16%)
Share & Embed Analysis
Last updated: October 02, 2026 3:45 AM ET
Data refreshes hourly during market hours. Next update: 4:45 AM
Data refreshes hourly during market hours. Next update: 4:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BAX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$84 | 50 HOLD |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$476 | 33 SELL |
|
RMD
ResMed Inc |
BUY
19 analysts |
$250 | 62 BUY |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$66 | 58 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$408 | 52 HOLD |
Advanced BAX Option Strategies
Professional options setups generated by AI based on today's BAX price and gamma walls.
